Last updated: 2026-09-07 11:42:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
The Cooper Companies, Inc. (COO) operates in the OPHTHALMIC GOODS sector and is listed on NASDAQ. The stock is currently priced at $69.56, with a market capitalization of $13.57B and a P/E ratio of 57.56. Over the past 52 weeks, its price has ranged from $58.89 to $89.83. This page covers its latest market performance, valuation, price trends and company information.
$13.57B | |
$70.33 | |
$115.90 | |
$2.54 | |
$70.64 | |
1.70M | |
2.34M | |
57.56 | |
$89.83 | |
$58.89 | |
-- | |
-- |
The Cooper Companies, Inc. (COO) last closed at $70.64 as of 2026-09-04 23:31:00, unchanged from the previous close of $70.64.
During the latest regular trading session, COO traded between $2.54 and $115.90, with a volume of 1.70M shares. The closing price was near the middle and near the middle of its 52-week range.
Over the past seven days, The Cooper Companies, Inc. (COO) moved from $70.96 to $69.56, representing a decline of 1.97% ($1.40).
The stock traded between $69.08 and $72.08 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 1.67 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 34.5%
COO is currently trading at $69.56, placing it 34.5% of the way from its 52-week low of $58.89 to its 52-week high of $89.83. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
| Industry | OPHTHALMIC GOODS |
| Employees | 15000 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of The Cooper Companies, Inc. (COO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.